David Liebowitz

David Liebowitz

Directeur Technique/Scientifique/R&D chez AVACTA GROUP PLC
Health Technology
Consumer Services
Retail Trade

Profil

David Neal Liebowitz is currently Chief Medical Officer at Avacta Group Plc since 2025.
Formerly, Dr. Liebowitz was Senior Vice President-Clinical Development at Inovio Pharmaceuticals, Inc. in 2022.
Served as Chief Medical Officer at Vaxart, Inc. from 2012 to 2018 and previously held the same title at Vaxart, Inc. without specified dates.
Held the position of Chief Scientific & Medical Officer at Vivaldi Biosciences, Inc. Worked as Medical Director at Immunex Corp.
from 2011 to 2013.
Was Chief Scientific Officer at Galileo Pharmaceuticals, Inc. from 2004 to 2008.
Served as Research Director at Amgen, Inc. Held the role of Associate Investigator at the University of Pennsylvania.
Worked as Assistant Professor-Medicine & Virology at The University of Chicago.
Held the position of Chief Marketing Officer at Xencor, Inc. Education includes undergraduate and graduate degrees from Emory University and a doctorate from The University of Chicago.

Postes actifs de David Liebowitz

SociétésPosteDébut
AVACTA GROUP PLC Directeur Technique/Scientifique/R&D 01/07/2025

Anciens postes connus de David Liebowitz

SociétésPosteFin
INOVIO PHARMACEUTICALS, INC. Directeur Technique/Scientifique/R&D 01/12/2022
VAXART, INC. Directeur Technique/Scientifique/R&D 01/05/2018
Directeur Technique/Scientifique/R&D 16/12/2008
XENCOR, INC. Sales & Marketing -
Directeur Technique/Scientifique/R&D -
Voir l'expérience en détail de David Liebowitz

Formation de David Liebowitz

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

22

Relations au 1er degré

12

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées12

Health Technology

Health Technology

Health Technology

Health Technology

Retail Trade

Consumer Services

Health Technology

Consumer Services

Consumer Services

Health Technology

Commercial Services

Health Technology

  1. Bourse
  2. Insiders
  3. David Liebowitz
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT